Shares of Alexion Pharmaceuticals (ALXN +2.8%) move higher again today, as rumors still swirl...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Shares of Alexion Pharmaceuticals (ALXN +2.8%) move higher again today, as rumors still swirl about a Roche (RHHBY.OB) takeover. Giving added lift is an article in Seeking Alpha suggesting the stock is poised to move up regardless of any buyout speculation. SA blog contributor Supreme Alpha points out the company has solid EPS and revenue growth rates of 37% and 46% respectively, which he thinks are the real drivers in the stock's outperformance. When you add to that mix a recently boosted FY forecast and the potential for a second drug to come to market, the commentator sees it as a great buying opportunity on its own merits.